Boston Epigenetics Society (BES) Meeting Feb 2024- Samir Ounzain, HAYA Therapeutics

Поділитися
Вставка
  • Опубліковано 20 жов 2024
  • Recording of the Boston Epigenetics Society (BES) online meeting February 29, 2024 with Samir Ounzain, Ph.D., CEO and Co-Founder of HAYA Therapeutics.
    "Unlocking the Regulatory Genome: Pioneering RNA-Guided Therapeutics for Cell-State Modulation in Disease Pathogenesis"

КОМЕНТАРІ • 2